Vector Science and Therapeutics Corp. Appoints Angus Jackson as Managing Director of Corporate Development
Jackson to lead organic and inorganic growth initiatives, strategic partnerships and corporate development as the Company advances its life sciences and therapeutics platforms TORONTO, Oct. 19, 2026 /PRNewswire/ -- Vector Science and Therapeutics Corp. (TSXV: PAIN) ("Vector" or the...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.